{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:26:54Z","timestamp":1793550414651,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12098-022-04265-2","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T08:06:02Z","timestamp":1658477162000},"page":"873-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gabapentin as Add-on Therapy to Trihexyphenidyl in Children with Dyskinetic Cerebral Palsy: A Randomized, Controlled Trial"],"prefix":"10.1007","volume":"90","author":[{"given":"Sonu","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-1830","authenticated-orcid":false,"given":"Jaya","family":"Shankar Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Dabla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"4265_CR1","first-page":"623","volume-title":"Advances in Pediatrics","author":"MG Shoals","year":"2007","unstructured":"Shoals MG. Cerebral palsy: diagnosis, risk factors, early intervention and management of the spastic child. In: Datta AK, Sachdeva A, editors. Advances in Pediatrics. 1st ed. New Delhi: Jaypee Publishers; 2007. p. 623\u20138.","edition":"1"},{"key":"4265_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/jpc.13754","volume":"54","author":"A Harvey","year":"2018","unstructured":"Harvey A, Reddihough D, Scheinberg A, Williams K. Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy. J Pediater Child Health. 2018;54:401\u20134.","journal-title":"J Pediater Child Health"},{"key":"4265_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1469-8749.1995.tb12022.x","volume":"37","author":"I Kr\u00e4geloh-Mann","year":"1995","unstructured":"Kr\u00e4geloh-Mann I, Petersen D, Hagberg G, Vollmer B, Hagberg B, Michaelis R. Bilateral spastic cerebral palsy-MRI pathology and origin: analysis from a representative series of 56 cases. Dev Med Child Neurol. 1995;37:379\u201397.","journal-title":"Dev Med Child Neurol"},{"key":"4265_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-2008-1071545","volume":"24","author":"M Steinlin","year":"1993","unstructured":"Steinlin M, Good M, Martin E, B\u00e4nziger O, Largo RH, Boltshauser E. Congenital hemiplegia: morphology of cerebral lesions and pathogenetic aspects from MRI. Neuropediatrics. 1993;24:224\u20139.","journal-title":"Neuropediatrics"},{"key":"4265_CR5","first-page":"67","volume":"13","author":"CL Truwit","year":"1992","unstructured":"Truwit CL, Barkovich AJ, Koch TK, Ferriero DM. Cerebral palsy: MR findings in 40 patients. AJNR Am J Neuroradiol. 1992;13:67\u201378.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4265_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0004-9514(14)60183-5","volume":"49","author":"DS Reddihough","year":"2003","unstructured":"Reddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother. 2003;49:7\u201312.","journal-title":"Aust J Physiother"},{"key":"4265_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1756285612447261","volume":"5","author":"CC Delnooz","year":"2012","unstructured":"Delnooz CC, van de Warrenburg BP. Current and future medical treatment in primary dystonia. Ther Adv Neurol Disord. 2012;5:221\u201340.","journal-title":"Ther Adv Neurol Disord"},{"key":"4265_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/WNL.53.4.871","volume":"53","author":"R Kumar","year":"1999","unstructured":"Kumar R, Dagher A, Hutchison WD, Lang AE, Lozano AM. Globus pallidus deep brain stimulation for generalized dystonia: clinical and PET investigation. Neurology. 1999;53:871\u20134.","journal-title":"Neurology"},{"key":"4265_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","volume":"20","author":"NY Liow","year":"2016","unstructured":"Liow NY, Gimeno H, Lumsden DE, et al. Gabapentin can significantly improve dystonia severity and quality of life in children. Eur J Pediatr Neurol. 2016;20:100\u20137.","journal-title":"Eur J Pediatr Neurol"},{"key":"4265_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pediatrneurol.2010.09.008","volume":"44","author":"J Carranza-del Rio","year":"2011","unstructured":"Carranza-del Rio J, Clegg NJ, Moore A, Delgado MR. Use of trihexyphenidyl in children in children with cerebral palsy. Pediatr Neurol. 2011;44:202\u20136.","journal-title":"Pediatr Neurol"},{"key":"4265_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0014-2999(99)00104-1","volume":"369","author":"A Richter","year":"1999","unstructured":"Richter A, L\u00f6scher W. Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis. Eur J Pharmacol. 1999;369:335\u20138.","journal-title":"Eur J Pharmacol"},{"key":"4265_CR12","first-page":"408","volume":"33","author":"CG Linazasoro","year":"2001","unstructured":"Linazasoro CG. Efficacy and tolerance of gabapentin in dystonia and hemifacial spasm: a pilot study. Rev Neurol. 2001;33:408\u201310.","journal-title":"Rev Neurol"},{"key":"4265_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1017\/S0317167100016759","volume":"41","author":"M Lerose","year":"2014","unstructured":"Lerose M, Di Fabio R, Serrao M, Loudianos G, Pierelli F, Casali C. Gabapentin can improve dystonia in confirmed Wilson disease. Canad J Neurol Sci. 2014;41:284\u20135.","journal-title":"Canad J Neurol Sci"},{"key":"4265_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/dmcn.12108","volume":"55","author":"DE Lumsden","year":"2013","unstructured":"Lumsden DE, Lundy C, Fairhurst C, Lin JP. Dystonia severity action plan: a simple grading system for medical severity of status dystonicus and life threatening dystonia. Dev Med Child Neurol. 2013;55:671\u20132.","journal-title":"Dev Med Child Neurol"},{"key":"4265_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1469-8749.2011.04209.x","volume":"54","author":"E Monbaliu","year":"2012","unstructured":"Monbaliu E, Ortibus E, De Cat J, et al. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol. 2012;54:278\u201383.","journal-title":"Dev Med Child Neurol"},{"key":"4265_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jfma.2015.11.002","volume":"114","author":"AW Hwang","year":"2015","unstructured":"Hwang AW, Yen CF, Liou TH, et al. Development and validation of the ICF-CY-based functioning scale of the disability evaluation system\u2013child version in Taiwan. J Formos Med Assoc. 2015;114:1170\u201380.","journal-title":"J Formos Med Assoc"},{"key":"4265_CR17","doi-asserted-by":"crossref","unstructured":"Harvey AR, Baker LB, Reddihough DS, Scheinberg A, Williams K. Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database Syst Rev. 2018;5:CD012430.","DOI":"10.1002\/14651858.CD012430.pub2"},{"key":"4265_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0887-8994(01)00287-9","volume":"25","author":"AH Hoon Jr","year":"2001","unstructured":"Hoon AH Jr, Freese PO, Reinhardt EM, et al. Age-dependant effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol. 2001;25:55\u20138.","journal-title":"Pediatr Neurol"},{"key":"4265_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0883073810392582","volume":"26","author":"H Ben-Pazi","year":"2011","unstructured":"Ben-Pazi H. Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. J Child Neurol. 2011;26:810\u20136.","journal-title":"J Child Neurol"},{"key":"4265_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1212\/WNL.36.2.160","volume":"36","author":"RE Burke","year":"1986","unstructured":"Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 1986;36:160\u20134.","journal-title":"Neurology"},{"key":"4265_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/dmcn.13452","volume":"59","author":"K Stewart","year":"2017","unstructured":"Stewart K, Harvey A, Johnston LM. A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy. Dev Med Child Neurol. 2017;59:786\u201395.","journal-title":"Dev Med Child Neurol"},{"key":"4265_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/0883073808322668","volume":"24","author":"J Rice","year":"2009","unstructured":"Rice J, Waugh MC. Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. J Child Neurol. 2009;24:176\u201382.","journal-title":"J Child Neurol"},{"key":"4265_CR23","doi-asserted-by":"crossref","unstructured":"Sanger TD, Bastian A, Brunstrom J, et al; Child Motor Study Group.\u00a0Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol. 2007;22:530\u20137.","DOI":"10.1177\/0883073807302601"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-022-04265-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T03:41:13Z","timestamp":1692070873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-022-04265-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1007\/s12098-022-04265-2","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}